Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 300% increase over the number of companies inspected in the previous quarter, when one company received one inspection.
Most of the companies inspected at the time were involved in the Biologics sector. The second most common type of company inspected worked in the Food and Cosmetics sector.
There were two companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Eyvazzadeh, Aimee, Inc., M.D. | Biologics | 02/07/2025 | No Action Indicated (NAI) |
| Reproductive Science Center of the San Francisco Bay Area, a Medical Corporation | Biologics | 02/05/2025 | Voluntary Action Indicated (VAI) |
| Sun Tropics, Inc. | Food and Cosmetics | 03/10/2025 | Voluntary Action Indicated (VAI) |
| VA Northern California, Health Care System | Biologics | 02/11/2025 | No Action Indicated (NAI) |
Alerts Sign-up